Jennifer E. Cameron, PhD completed her degree in Microbiology, Immunology and Parasitology at LSU Health Sciences Center in New Orleans in 2004. She was appointed as a Postdoctoral Fellow in Virology at Harvard Medical School in Boston, followed by a second Postdoctoral Fellowship appointment in the Cancer Center at Tulane University Health Sciences Center in New Orleans. As a Fellow at Tulane University, Dr. Cameron was a recipient of the Individual National Research Service Award (NRSA) sponsored by the National Cancer Institute at the National Institutes of Health. She is now an Assistant Professor in the Department of Microbiology, Immunology and Parasitology at LSU.
Dr. Cameron’s research interests are in investigating the mechanisms by which DNA tumor viruses such as human papillomavirus (HPV) and Epstein-Barr virus (EBV) interact with the host and promote cancer. Her ultimate goal is to translate her findings into improved diagnostic and prognostic cancer screening tests, cancer prevention, and cancer treatment. A main focus of her research is revealing the role of small non-coding RNAs known as microRNAs in regulating and/or promoting virus-mediated oncogenesis. Dr. Cameron’s work has demonstrated induction of microRNA-146 (miR-146) by the EBV oncoprotein LMP-1, and current studies are using state-of-the-art techniques to identify the cellular transcripts and pathways targeted by miR-146. Current evidence suggests that miR-146 functions to suppress both inflammation and cancer metastasis, making miR-146 an attractive candidate for use as a therapeutic agent. Dr. Cameron is also evaluating miRNAs as the targets of next-generation screening tests for cervical cancer.